GSK to produce 1 billion doses of coronavirus vaccine booster in 2021Britain's GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, next year as the The United States last week secured almost a third of the first 1 billion doses planned for AstraZeneca's (AZN.L) experimental covid-19 vaccine by pledging…

…billion doses of vaccine efficacy boosters for COVID-19 shots next year, as the race to develop a successful solution to the coronavirus crisis heats up. GSK shares were up 1.4 percent at 1,671.2 pence by 09:16 GMT. Booster shot. Experts have predicted that a successful vaccine will take more…

GSK , the world’s largest vaccine maker, laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters …

Britain’s GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, …

The adjuvant could be a critical ingredient in at least seven experimental vaccines against the new coronavirus.

GlaxoSmithKline plans to produce 1 billion doses of a vaccine adjuvant — a booster that can help any brand of shot — to support immunization against the COVID-19 pandemic next year. The adjuvant can reduce the amount of vaccine required per dose, allowing more people to be immunized…